Company Profiles

driven by the PitchBook Platform

HemoShear Therapeutics

Description

Operator of a discovery-stage biotechnology company. The company focuses on developing therapies for rare metabolic disorders of the liver and nonalcoholic steatohepatitis (NASH), using a novel approach to elucidate the rue underlying biology of disease.

2008

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$18.2M

Total Amount Raised

3

Investors

Description

Operator of a discovery-stage biotechnology company. The company focuses on developing therapies for rare metabolic disorders of the liver and nonalcoholic steatohepatitis (NASH), using a novel approach to elucidate the rue underlying biology of disease.

Website:

www.hemoshear.com

Formerly Known As

HemoShear

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

501 Locust Avenue Suite 301 Charlottesville, VA 22902United States +1 (434) 872-0196
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore HemoShear Therapeutics's full profile, request a free trial.

HemoShear Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

HemoShear Therapeutics Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Ed WilliamsAngel (individual)Minority000 0000000 0000
Main Line Equity PartnersPE/BuyoutMinority000 0000000 0000
Virginia Capital PartnersVenture CapitalMinority000 0000000 0000
Ed Williams Angel (individual)
Main Line Equity Partners PE/Buyout
Virginia Capital Partners Venture Capital

HemoShear Therapeutics Executive Team (12)

NameTitleBoard
Seat
Contact
Info
James PowersChief Executive Officer & Chairman
Brian Campbell Ph.DChief Financial Officer, Vice Chairman & Chairman of the Audit Committee
Richard White Jr.Vice President, Finance & Controller
Aaron MackeyDirector of Quantitative and Computational Science
David MankaDirector of Translational Science
James Powers Chief Executive Officer & Chairman
Brian Campbell Ph.D Chief Financial Officer, Vice Chairman & Chairman of the Audit Committee
Richard White Jr. Vice President, Finance & Controller
Aaron Mackey Director of Quantitative and Computational Science
David Manka Director of Translational Science

HemoShear Therapeutics Board Members (8)

NameRepresentingRoleSinceContact
Info
Brian Campbell Ph.DHemoShear TherapeuticsChief Financial Officer, Vice Chairman & Chairman of the Audit Committee000 0000
James PowersHemoShear TherapeuticsChief Executive Officer & Chairman000 0000
John Brooks IIISelfBoard Member000 0000
Mehmood Khan MDSelfBoard Member000 0000
Reginald WoodsSelfBoard Member000 0000
Brian Campbell Ph.D Chief Financial Officer, Vice Chairman & Chairman of the Audit Committee HemoShear Therapeutics
James Powers Chief Executive Officer & Chairman HemoShear Therapeutics
John Brooks III Board Member Self
Mehmood Khan MD Board Member Self
Reginald Woods Board Member Self
Request full access to PitchBook